Korean Society of Hematology
Korean Society of Hematology
Explore linked clinical trials.3 results ยท Page 1 of 1
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Selinexor With ICE Chemotherapy in Secondary Central Nervous System Involving B-cell Non-Hodgkin Lymphoma | B-cell Lymphoma Recurrent; B-cell Lymphoma Refractory; CNS Metastases | Recruiting | Phase 1 / Phase 2 | 2026-04-23 | NCT06552559 | |
| A Study of Treatment-free Remission in Chronic Phase Chronic Myeloid Leukemia | Chronic Disease, Disease Attributes, Hemic and Lymphatic Diseases, Leukemia, Myelogenous, Chronic, BCR-ABL Positive, Leukemia, Myeloid, Chronic-Phase, Myeloproliferative Disorders, Neoplasms by Histologic Type, Pathologic Processes, Pathological Conditions, Signs and Symptoms, bone marrow disorder, hematologic disorder, leukemia, myeloid leukemia, neoplasm | Recruiting | Phase 2 | 2026-04-02 | NCT06368414 | |
| Venetoclax and Decitabine in R/R T-ALL | Hemic and Lymphatic Diseases, Neoplasms by Histologic Type, T lymphoblastic leukemia/lymphoma, immune system disorder, immunoproliferative disorder, lymphatic system disorder, lymphoma, lymphoproliferative syndrome, neoplasm | Recruiting | Phase 2 | 2026-02-02 | NCT06712121 |